← Leaderboards
Ronald L Cihlar
Georgetown University
$4,039,890
Attributed
$4,039,890
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $194K · FY2005–06$200K$150K$100K$50K$0
'05
'06
Funding mix
By agency
NIH$4,039,890 · 3
By mechanism
R01$3,661,840 · 2
R21$378,050 · 1
Top collaborators
No co-investigators on record.
Most similar at Georgetown University
Same institution · by research overlap
- Richard Arthur Calderone$6,243,756
- Joy E Sturtevant$2,324,473
- John L. Marshall$2,076,333
Others in their field
Top investigators on “Candida Albicans”
- Alexander D Johnson · University Of California San Francisco$23,545,370
- Aaron P Mitchell · La Biomed Res Inst/ Harbor Ucla Med Ctr$20,872,115
- Gavin J Sherlock · Stanford University$18,218,461
- Jay B Jackson · Johns Hopkins University$17,529,470
- Scott G Filler · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center$14,524,347
- Gerald R Fink · Whitehead Institute For Biomedical Res$14,278,186
Research focus
Candida AlbicansCandidiasisTissue /Cell CultureAspergillusBiological ModelsClinical ResearchDifferential Display TechniqueDrug Screening /EvaluationFatty Acid SynthaseFunctional /Structural GenomicsGene ExpressionGene TargetingGenetically Modified AnimalsGlucansVirulenceAntifungal AgentsAspergillosisProtein Structure FunctionTranscription FactorTransferaseTranslation FactorAidsHigh Throughput TechnologyHistidine
Grant awards (10)
Cranberry Effect on C. albicans Adherence and Biofilms$184,050
R21 · FY2006 · AT · contact PI
Cranberry Effect on C. albicans Adherence and Biofilms$194,000
R21 · FY2005 · AT
AIDS-RELATED CANDIDIASIS: IN VIVO GENE EXPRESSION$288,672
R01 · FY2004 · DE
NEW APPROACHES TO TARGET SPECIFIC ANTIFUNGAL AGENTS$643,219
R01 · FY2003 · CA
AIDS-RELATED CANDIDIASIS: IN VIVO GENE EXPRESSION$288,672
R01 · FY2003 · DE
NEW APPROACHES TO TARGET SPECIFIC ANTIFUNGAL AGENTS$628,269
R01 · FY2002 · CA
AIDS-RELATED CANDIDIASIS: IN VIVO GENE EXPRESSION$288,672
R01 · FY2002 · DE
NEW APPROACHES TO TARGET SPECIFIC ANTIFUNGAL AGENTS$611,210
R01 · FY2001 · CA
AIDS-RELATED CANDIDIASIS: IN VIVO GENE EXPRESSION$289,292
R01 · FY2001 · DE
NEW APPROACHES TO TARGET SPECIFIC ANTIFUNGAL AGENTS$623,834
R01 · FY2000 · CA